Gonane Triamcinolone Acetonide Gonane Triamcinolone Acetonide

X

Find Radio Compass News for Triamcinolone Acetonide

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • INJECTABLE;INJECTION - 10MG/ML
  • SPRAY;TOPICAL - 0.147MG/GM
  • INJECTABLE;INJECTION - 40MG/ML
  • INJECTABLE;INJECTION - 80MG/ML
  • SPRAY, METERED;NASAL - 0.055MG/SPRAY
  • FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL
  • CREAM;TOPICAL - 0.025%
  • CREAM;TOPICAL - 0.1%
  • CREAM;TOPICAL - 0.5%
  • OINTMENT;TOPICAL - 0.025%
  • OINTMENT;TOPICAL - 0.1%
  • OINTMENT;TOPICAL - 0.5%

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-11-2023-46012.pdf

FDA
11 Oct 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216625

FDA
18 Aug 2023

https://www.fiercepharma.com/pharma/novartis-isnt-done-shaking-things-sells-five-eyecare-drugs-harrow-130-million

Zoey Becker FIERCEPHARMA
15 Dec 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212567

FDA
02 Nov 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-21-2022-99399.pdf

FDA
21 Sep 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214181

FDA
13 Jul 2022

https://www.prnewswire.com/news-releases/bausch--lomb-announces-scientific-data-on-xipere-triamcinolone-acetonide-injectable-suspension-to-be-presented-during-the-american-society-of-retina-specialists-annual-scientific-meeting-301581017.html

PRNEWSWIRE
06 Jul 2022

https://health.economictimes.indiatimes.com/news/pharma/aurobindo-pharma-arm-receives-usfda-nod-for-triamcinolone-acetonide-injectable-suspension/92702483

ET HEALTH
06 Jul 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212400

FDA
05 Jul 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-30-2022-1648618596.pdf

FDA
30 Mar 2022

https://www.prnewswire.com/news-releases/bausch--lomb-and-clearside-biomedical-announce-the-us-commercial-launch-of-xipere-triamcinolone-acetonide-injectable-suspension-for-suprachoroidal-use-for-the-treatment-of-macular-edema-associated-with-uveitis-301511357.html

PRNEWSWIRE
28 Mar 2022

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharmaceuticals-jv-gets-usfda-final-nod-for-anti-fungal-drug/articleshow/90071578.cms

ECONOMIC TIMES
08 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214186

FDA
04 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213543

FDA
19 Jan 2022

https://www.prnewswire.com/news-releases/arctic-vision-announces-first-patient-dosed-in-phase-iii-study-of-arvn001-for-treatment-of-macular-edema-associated-with-uveitis-ume-301429973.html

PRNEWSWIRE
22 Nov 2021

https://www.expresspharma.in/bausch-and-clearside-biomedical-announce-fda-approval-of-xipere/

EXPRESS PHARMA
25 Oct 2021

https://www.globenewswire.com/news-release/2021/09/09/2294162/0/en/Clearside-Biomedical-Expands-XIPERE-License-Agreement-with-Arctic-Vision-to-Include-Australia-New-Zealand-India-and-ASEAN-Countries.html

GLOBENEWSWIRE
09 Sep 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf

FDA
25 Aug 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214751

FDA
18 Aug 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=141871&sid=2

PHARMABIZ
17 Aug 2021

https://www.prnewswire.com/news-releases/innovent-announces-sintilimab-in-combination-with-chemotherapy-meets-the-primary-endpoint-of-overall-survival-in-the-phase-3-orient-16-study-for-the-first-line-treatment-of-advanced-or-metastatic-gastric-or-gastroesophageal-juncti-301355470.html

PR NEWSWIRE
15 Aug 2021

https://www.globenewswire.com/news-release/2021/05/12/2228643/29848/en/Flexion-Therapeutics-Reports-First-Quarter-2021-Financial-Results-and-Recent-Business-Updates.html#:~:text=First%2DQuarter%20Results%20%26%20Financial%20Highlights,%2C%202021%20and%202020%2C%20respectively.

GLOBENEWSWIRE
12 May 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=136491&sid=2

PHARMABIZ
31 Mar 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-2-2020-1606885653.pdf

FDA
02 Dec 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213619

FDA
12 Nov 2020

https://www.globenewswire.com/news-release/2020/09/23/2097880/0/en/Clearside-Biomedical-Announces-Clinical-Data-Presentations-at-The-Retina-Society-2020-and-Publication-of-XIPERE-Data-in-Diabetic-Macular-Edema-in-Ophthalmology-Retina.html

GLOBENEWSWIRE
23 Sep 2020

https://www.globenewswire.com/news-release/2020/08/24/2082531/0/en/Medexus-Reports-Triamcinolone-Hexacetonide-Injectable-Suspension-Approved-for-Inclusion-on-Quebec-s-RAMQ-List-of-Medications-Basic-Plan-and-Institutions.html

GLOBENEWSWIRE
24 Aug 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213142

FDA
18 Jul 2020

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-8-2020-1594182255.pdf

FDA
08 Jul 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213559

FDA
08 Jul 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212356

FDA
06 Jun 2020

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-gets-usfda-nod-for-generic-ointment-to-treat-skin-conditions/articleshow/76151188.cms

ECONOMICTIMES
02 Jun 2020

https://www.globenewswire.com/news-release/2020/04/01/2009879/0/en/Flexion-Therapeutics-Announces-ZILRETTA-License-Agreement-and-Provides-Business-Update-Amid-Coronavirus-Pandemic.html

GLOBENEWSWIRE
01 Apr 2020

https://www.prnewswire.com/news-releases/bausch-health-and-clearside-biomedical-announce-publication-of-pivotal-phase-3-data-on-xiperetm-triamcinolone-acetonide-suprachoroidal-injectable-suspension-in-ophthalmology-300994122.html

PR NEWSWIRE
28 Jan 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212356

FDA
23 Jan 2020

https://www.marketwatch.com/story/flexion-therapeutics-stock-soars-24-premarket-as-fda-approves-label-change-for-oa-keen-pain-therapy-2019-12-27

MARKET WATCH
28 Dec 2019

https://www.pharmacompass.com/pdf/news/farmabios-spa-fails-edqm-inspection-1575005454.pdf

EDQM
23 Nov 2019

https://endpts.com/clearside-biomedical-predicts-its-uveitis-drug-will-be-rejected-after-fda-requests-more-data/

Natalie Grover ENDPTS
24 Aug 2019

https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=6312019105346

FDA
31 Jul 2019

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-subsidiary-sells-assigns-us-rights-for-3-brands-to-encore-dermatology/articleshow/68683488.cms

ECONOMIC TIMES
03 Apr 2019

https://www.biospace.com/article/releases/encore-dermatology-inc-acquires-sernivo-trianex-and-promiseb-/?s=79

BIOSPACE
02 Apr 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210346

FDA
14 Feb 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209828

FDA
27 Nov 2018

https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/68348r-eng.php

HEALTH CANADA
23 Nov 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207764

FDA
09 Nov 2018

https://endpts.com/clearside-bio-loses-nearly-half-its-value-pre-market-as-lead-eye-drug-fails-pivotal-test/

ENDPTS
05 Nov 2018

https://www.fiercebiotech.com/biotech/clearside-slides-as-eye-drug-xipere-flunks-combination-study

Phil Taylor FIERCE BIOTECH
05 Nov 2018

https://www.livemint.com/Companies/4PZEkzoLN49OJlBBXLNVjI/Dr-Reddys-Labs-recalls-35000-tubes-of-skin-infection-cream.html

LIVEMINT
14 Oct 2018

https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=910201811531

FDA
10 Oct 2018

https://www.prnewswire.com/news-releases/imprimis-announces-multi-center-clinical-trial-for-dropless-trimoxi-triamcinolone-acetonide-moxifloxacin-for-injection-formulation-in-canada-300689876.html

PR NEWSWIRE
02 Aug 2018
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY